Gut immune system homeostasis involves diverse structural interactions among resident microbiota, the protective mucus layer, and a variety of cells (intestinal epithelial, lymphoid, and myeloid). Due to the substantial surface area in direct contact with an "external" environment and the diversity of xenobiotic, abiotic, and self-interactions coordinating to maintain gut homeostasis, there is enhanced potential for the generation of endogenous danger signals when this balance is lost. Here, we focus on the potential generation and reception of damage in the gut resulting from exposure to nanoparticles (NPs), common food and drug additives. Specifically, we describe recent evidence in the literature showing that certain NPs are potential generators of damage-associated molecular patterns, as well as potential immune-stimulating molecular patterns themselves.
K E Y W O R D SATP, DAMP, mtDNA, NAMP, Nanoparticles, NLRP3Over the past decade, the commercial use of NPs by the food and biomedical industries has seen immense growth. The small, nanoscale size of NPs confers unique physicochemical properties that allow them to be effective oral delivery mechanisms for pharmaceuticals, food flavors, nutrient additives, and more. The accepted size range of NPs is not straightforward, varying across different biomedical and engineering disciplines and government agencies. 10,11 Although certain sources indicate that a typical NP is 1-100 nm in three dimensions, other sources consider accepted dimensions (one or more) for NPs to include <200 nm, 12 <500 nm, 13 or as large as <1000 nm. 14,15 The ASTM International definition provides for either two or three dimensions at the nanoscale, 16 whereas the ISO definition indicates nanoscale in three dimensions. 17 In an officially issued